These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1975178)

  • 21. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
    Hannuksela ML; Liinamaa MJ; Kesäniemi YA; Savolainen MJ
    Atherosclerosis; 1994 Sep; 110(1):35-44. PubMed ID: 7857368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity.
    Kakko S; Tamminen M; Kesäniemi YA; Savolainen MJ
    Atherosclerosis; 1998 Feb; 136(2):233-40. PubMed ID: 9543093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Variability gene" effect of cholesteryl ester transfer protein (CETP) genes.
    Berg K; Kondo I; Drayna D; Lawn R
    Clin Genet; 1989 Jun; 35(6):437-45. PubMed ID: 2567644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan.
    Wu JH; Lee YT; Hsu HC; Hsieh LL
    Atherosclerosis; 2001 Dec; 159(2):451-8. PubMed ID: 11730826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Nishizawa Y
    Diabetes; 2002 Mar; 51(3):871-4. PubMed ID: 11872695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in Saudis.
    Al-Daghri NM; Al-Attas O; Patel A; Belyaev ND; Bartlett WA; Jones AF; Kumar S; Bain SC
    Clin Sci (Lond); 2003 Oct; 105(4):467-72. PubMed ID: 12773093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common variants of apolipoprotein E and cholesteryl ester transport protein genes in male patients with coronary heart disease and variable body mass index.
    Kolovou GD; Panagiotakos DB; Kolovou V; Vasiliadis I; Giannakopoulou V; Diakoumakou O; Katsiki N; Mavrogeni S
    Angiology; 2015 Feb; 66(2):169-73. PubMed ID: 24402318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and associations of apolipoprotein A-I linked DNA polymorphisms: results from a population study.
    Anderson RA; Benda TJ; Wallace RB; Eliason SL; Lee J; Burns TL
    Genet Epidemiol; 1986; 3(6):385-97. PubMed ID: 2879769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.
    Agerholm-Larsen B; Tybjaerg-Hansen A; Schnohr P; Steffensen R; Nordestgaard BG
    Circulation; 2000 Oct; 102(18):2197-203. PubMed ID: 11056092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.